This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Hanmi Pharmaceutical Co., Ltd.
Drug Names(s): LAPS-EPO
Description: HM10760A is a long-acting erythropoietin (EPO) developed as a monthly administration therapy for anemia using Hanmi's LAPSCOVERY technology.
EPO is a hormone produced by the kidney that promotes the formation of red blood cells in the bone marrow. The kidney cells that make EPO are specialized and are sensitive to low oxygen levels in the blood. These cells release EPO when the oxygen level is low in the kidney. EPO then stimulates the bone marrow to produce more red cells and thereby increase the oxygen-carrying capacity of the blood.
Pink Sheet Office for Human Research Trials
Additional information available to subscribers only: